Targeting TGF-β Signaling in Kidney Fibrosis

Area of Science:

• Nephrology
• Cell Biology
• Biochemistry

Background:

• Renal fibrosis is a common endpoint for many chronic kidney diseases.
• Transforming growth factor-β (TGF-β) plays a critical role in promoting kidney fibrosis.
• TGF-β signaling influences matrix protein synthesis, degradation, and cell interactions in fibrotic kidneys.

Purpose of the Study:

• To review and summarize therapeutic strategies targeting the TGF-β signaling pathway in the context of kidney fibrosis.
• To provide an overview of approaches investigated for treating fibrotic kidney diseases.

Main Methods:

• Literature review of studies on TGF-β targeting strategies.
• Analysis of approaches applied in kidney fibrosis, other fibrotic diseases, and cancer.
• Examination of clinical studies involving TGF-β inhibitors for kidney fibrosis.

Main Results:

• Multiple strategies targeting TGF-β signaling have been developed, including inhibiting its production, activation, receptor binding, and downstream signaling.
• Some TGF-β targeting strategies have progressed to clinical trials for kidney fibrosis.
• These approaches have also found applications in treating other fibrotic conditions and cancers.

Conclusions:

• Targeting TGF-β signaling represents a promising therapeutic avenue for managing renal fibrosis.
• Further research and clinical evaluation are warranted to optimize these strategies for kidney disease treatment.
• Understanding TGF-β's multifaceted role is key to developing effective anti-fibrotic therapies.